Comparative efficacy of adjuvant trastuzumab-containing chemotherapies for patients with early HER2-positive primary breast cancer: a network meta-analysis Y. ShenT. FujiiL. Xiao Review 21 September 2018 Pages: 1 - 9
T-Type voltage gated calcium channels: a target in breast cancer? Anamika BhargavaSumit Saha Review 21 September 2018 Pages: 11 - 21
Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis April Phantana-angkoolMeghan R. ForsterRichard L. White Jr. Review 21 September 2018 Pages: 23 - 29
Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty Ken ResnicowMinal R. PatelReshma Jagsi Review 26 September 2018 Pages: 31 - 36
Male breast cancer: a disease distinct from female breast cancer Ayca GucalpTiffany A. TrainaFatima Cardoso Review 28 September 2018 Pages: 37 - 48
BRCA mutations: is everything said? Eduardo López-UrrutiaVictor Salazar-RojasCarlos Pérez-Plasencia Review 06 October 2018 Pages: 49 - 54
The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review C. J. H. KramerK. M. H. VangangeltW. E. Mesker Review Open access 09 October 2018 Pages: 55 - 64
Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature Anaeze C. Offodile IICindy GuCharles Butler Review 10 October 2018 Pages: 65 - 77
A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers Ciyu YangOzge Ceyhan-BirsoyLiying Zhang Preclinical study 25 September 2018 Pages: 79 - 86
Alternative splicing is an important mechanism behind KAI1 loss of function in breast cancer patients from Saudi Arabia Haitham KussaibiKhaled R. AlkharsahEman Mohammad Abdullah Alsulami Preclinical study 10 October 2018 Pages: 87 - 91
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer Lutfi H. AlfarsiRokaya ElansariAndrew R. Green Preclinical study 10 October 2018 Pages: 93 - 102
Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials Saroj NiraulaBishal Gyawali Clinical trial 20 September 2018 Pages: 103 - 109
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact Gilles HouvenaeghelAlexandre de NonnevilleEric Lambaudie Clinical trial 20 September 2018 Pages: 111 - 122
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study Hiroji IwataNorikazu MasudaYasuo Ohashi Clinical trial Open access 21 September 2018 Pages: 123 - 133
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer Katharina SmetanayPhilippe JunioFrederik Marmé Clinical trial 25 September 2018 Pages: 135 - 143
Dietary intervention among breast cancer survivors increased adherence to a Mediterranean-style, anti-inflammatory dietary pattern: the Rx for Better Breast Health Randomized Controlled Trial Krystle E. ZunigaDorothy Long ParmaAmelie G. Ramirez Clinical trial 26 September 2018 Pages: 145 - 154
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer Sarah F. JauchSabine RiethdorfAndreas Schneeweiss Clinical trial 01 October 2018 Pages: 155 - 165
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates Wei Lue TongBlake M. CallahanGeorge Blanck Epidemiology 18 September 2018 Pages: 167 - 177
The association of socioeconomic status with receipt of neoadjuvant chemotherapy Joan M. NeunerAmanda KongMary Schroeder Epidemiology 19 September 2018 Pages: 179 - 188
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? Se Kyung LeeSeok Won KimKorean Breast Cancer Society Epidemiology 20 September 2018 Pages: 189 - 199
Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions Francisco AcevedoV. Diego ArmengolKevin S. Hughes Epidemiology 20 September 2018 Pages: 201 - 207
Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database Enoch ChangSarah S. MougalianJames B. Yu Epidemiology 21 September 2018 Pages: 209 - 216
Psychosocial stress is associated with benign breast disease in young Chinese women: results from Project ELEFANT Timothy M. BarrowCheng PengHyang-Min Byun Epidemiology 25 September 2018 Pages: 217 - 224
Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics Jin-Xiao RenYue GongZhi-Ming Shao Epidemiology Open access 06 October 2018 Pages: 225 - 237
Regular exercise might be associated with higher skeletal muscle volume, favorable prognostic factor in breast cancer patients Kadri Altundag Letter to the Editor 03 September 2018 Pages: 239 - 239
Association between red and processed meat with breast cancer: Comment on “Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies” by Guo et al. Ran XuJing Zhu Letter to the Editor 24 September 2018 Pages: 241 - 242
Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung Brennan McCullarManjari PandeyMichael G. Martin Correction 11 October 2018 Pages: 243 - 243
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer K. A. NyropA. M. DealH. B. Muss Correction 11 October 2018 Pages: 245 - 245
